FOXO1 and acute lymphoblastic leukemia: In contrast, genetic and pharmacological inactivation of FOXO1 produces a tumour suppressive effect by means of caspase-induced cell death in pre-BCR- and pre-BCR+ BCP-ALL cells via CCND3 downregulation (99, 100).